IPO Timeline
Broker Results (T-2)
2022-03-18
Some brokers release in afternoon
Grey Market (T-1)
2022-03-21
Afternoon
HKEX Allotment (T-1)
2022-03-21
Evening
Registrar Allotment (T-1)
2022-03-21
Evening
Listing Day (T)
2022-03-22
First day of trading
Company Overview
| Stock Name | 瑞爾集團有限公司 |
|---|---|
| Stock Code | 06639 |
| Company Full Name | 瑞爾集團有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國以「瑞泰口腔」及「瑞爾齒科」品牌從事經營口腔診所及醫院。 |
| Listing Date | 2022-03-22 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市朝陽區朝來高科技產業園紫月路18號院11號樓6層 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.arrailgroup.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 14.62 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 74.7% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 68,026,860 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 13.8 |
|---|---|
| First Day Open | HK$ 14.6 |
| First Day Change | -5.61% |
| First Day Volume | 6072000.0 |
| First Day Turnover | 84333900.0 |
Use of Proceeds
| Use of Proceeds | 1、約75%（或442.4百萬港元）將用于業務擴張、在現有及新城市開設新的瑞爾齒科和瑞泰口腔的醫院及診所； 2、約15%（或88.5百萬港元）將用于建設及優化我們的信息技術基礎設施； 3、約10%（或59.0百萬港元）將用作營運資金，以繼續為客戶提供優質的口腔醫療服務，通過采取以下舉措。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
摩根士丹利亚洲有限公司 CE AAD291
UBS Securities Hong Kong Limited CE BIN466
Overall Coordinators (4)
摩根士丹利亚洲有限公司 CE AAD291
UBS Securities Hong Kong Limited CE BIN466
中国国际金融香港证券有限公司 CE AEN894
海通国际证券有限公司 CE AAF806
Joint Bookrunners (7)
摩根士丹利亚洲有限公司 CE AAD291
UBS Securities Hong Kong Limited CE BIN466
中国国际金融香港证券有限公司 CE AEN894
海通国际证券有限公司 CE AAF806
香港上海汇丰银行有限公司
富途证券国际（香港）有限公司 CE AZT137
招银国际融资有限公司 CE AVM940
Joint Lead Managers (7)
摩根士丹利亚洲有限公司 CE AAD291
UBS Securities Hong Kong Limited CE BIN466
中国国际金融香港证券有限公司 CE AEN894
海通国际证券有限公司 CE AAF806
香港上海汇丰银行有限公司
富途证券国际（香港）有限公司 CE AZT137
招银国际融资有限公司 CE AVM940
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Abax Asian Structured Private Credit Fund III, LP | 195,330,510 HKD | — | 28.72% | — | 6 months | 2022-09-22 |
| 2 | Harvest International Premium Value (Secondary Market) Fund SPC | 156,258,560 HKD | — | 22.97% | — | 6 months | 2022-09-22 |
| 3 | Hudson Bay Master Fund LTD | 78,129,280 HKD | — | 11.49% | — | 6 months | 2022-09-22 |
| 4 | OrbiMed Funds | 39,064,640 HKD | — | 5.74% | — | 6 months | 2022-09-22 |
| 5 | 高鹏(香港)有限公司 | 39,064,640 HKD | — | 5.74% | — | 6 months | 2022-09-22 |
Directors & Management
| Chairman | 鄒其芳 |
|---|---|
| Company Secretary | 區慧晶 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 鄒其芳(10.92%);淡馬錫控股(私人)有限公司(10.01%);19 Growth Capital Fund LP(9.50%);The Goldman Sachs Group, Inc.(7.58%);KPCB China Fund, L.P.(5.40%);Qiming GP II, L.P.(5.10%) |
|---|
IPO Timeline
